First drug to improve heart failure mortality in over a decade European Society of Cardiology

<P>Contact: Jacqueline Partarrieu<BR>press@escardio.org<BR>33-492-947-756<BR>European Society of Cardiology <BR>
<P>Lisbon, 25 May 2013: Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality in over a decade and should be added to standard treatment, according to lead author Professor

Read more ...